HCAD:LSE:LSE-HSBC ETFs Public Limited Company - HSBC MSCI Canada UCITS ETF (USD)

ETF | Others |

Last Closing

USD 23.91

Change

-0.33 (-1.36)%

Market Cap

N/A

Volume

3.59K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 557.54B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 496.18B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
0QZO:LSE 0QZO

N/A

USD 258.54B
0QZ3:LSE Qualcomm Inc.

N/A

USD 202.26B
PRJU:LSE Amundi Index Solutions - Amund..

N/A

USD 200.01B
0R24:LSE Intel Corp.

N/A

USD 196.14B

ETFs Containing HCAD:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.42% 60% D- 60% D-
Dividend Return 2.19% 67% D+ 82% B
Total Return 9.62% 67% D+ 66% D+
Trailing 12 Months  
Capital Gain 14.80% 63% D 63% D
Dividend Return 2.34% 63% D 80% B-
Total Return 17.14% 70% C- 68% D+
Trailing 5 Years  
Capital Gain 38.71% 60% D- 66% D+
Dividend Return 6.71% 65% D 75% C
Total Return 45.42% 64% D 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 8.98% N/A N/A 67% D+
Dividend Return 9.94% N/A N/A 69% C-
Total Return 0.96% N/A N/A 71% C-
Risk Return Profile  
Volatility (Standard Deviation) 18.01% N/A N/A 55% F
Risk Adjusted Return 55.21% N/A N/A 78% C+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike